StockNews.AI
INSP
StockNews.AI
7 days

INSPIRE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Inspire Medical Systems, Inc. on Behalf of Inspire Stockholders and Encourages Investors to Contact the Firm

1. Bragar Eagel & Squire is investigating Inspire for potential securities violations. 2. Inspire cut its full-year earnings guidance significantly from previous estimates. 3. Stock price fell by $46.44 to $83.51 following the guidance reduction. 4. Management cited rollout delays and higher demand for Inspire IV devices.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The drastic cut in earnings forecasts after a prior increase signals fundamental issues. Historically, similar announcements led to sustained drops in stock values, as seen with other biotech firms facing operational setbacks.

How important is it?

The combination of legal actions and severe earnings guidance cuts could significantly threaten investor confidence and stock stability. The ongoing scrutiny raises serious questions regarding Inspire's business practices and future earnings.

Why Short Term?

Immediate impact from earnings guidance and ongoing legal investigations suggests short-term volatility. Examples from prior cases, like NANT, demonstrated how legal concerns quickly affected stock prices.

Related Companies

NANT
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire (INSP) To Contact Him Directly To Discuss Their Options If you purchased or acquired Inspire stock and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) on behalf of Inspire stockholders. Our investigation concerns whether Inspire has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On August 5, 2025, Inspire issued a press release announcing better-than-expected second quarter fiscal 2025 results, but surprisingly also slashed its full-year guidance from anticipated earnings of $2.20 - $2.30 on revenue of $940m - $955m down to earnings of $0.40 - $0.50 on revenue of $900m - $910m. This follows Inspire raising its earnings guidance only one quarter ago. Management blamed the guidance setback on slowdowns related to the recent rollout of Inspire V. The company disclosed that the commercial rollout "encountered certain headwinds" such as centers failing to complete training and onboarding criteria, customer delays, technical Medicare adoption delays, and continued higher demand for Inspire IV devices. Following this news, Inspire's stock price fell by $46.44 per share to open at $83.51 per share. If you purchased or otherwise acquired Inspire shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News